Beverley Balkau

Papers

Total Citations

H-Index

About

Beverley Balkau is a leading epidemiologist whose research has profoundly shaped our understanding of metabolic diseases, particularly type 2 diabetes and its complications. Her seminal work on the natural history of diabetes, including the pivotal role of insulin resistance and the metabolic syndrome, has been cited over 30,000 times, establishing her as a highly influential figure in the field. She is best known for her contributions to large-scale cohort studies, such as the French D.E.S.I.R. study, which provided critical insights into the progression from normal glucose tolerance to diabetes. Her research has also advanced knowledge on the link between lifestyle factors, such as physical activity and diet, and cardiovascular risk. Beyond her core metabolic work, Balkau has recently applied her expertise to health economics and surgical outcomes, notably co-authoring a 2023 study on the cost-effectiveness of robotic-assisted versus open partial nephrectomy for small kidney tumors. This work demonstrates her versatility and commitment to evidence-based medicine, evaluating the real-world benefits of modern surgical technologies. A highly cited researcher, Balkau’s legacy lies in her rigorous, population-based investigations that have directly informed clinical guidelines and public health strategies for diabetes prevention and management.